BR1100393A - Composto e formulação farmacêutica - Google Patents

Composto e formulação farmacêutica

Info

Publication number
BR1100393A
BR1100393A BR1100393-6A BR1100393A BR1100393A BR 1100393 A BR1100393 A BR 1100393A BR 1100393 A BR1100393 A BR 1100393A BR 1100393 A BR1100393 A BR 1100393A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
BR1100393-6A
Other languages
English (en)
Inventor
James E Audia
Kenneth S Hirsch
Charles D Jones
David E Lawhorn
Loretta A Mcquaid
Leland O Weigel
Original Assignee
James E. Audia
Kenneth S. Hirsch
Charles D. Jones
David E. Lawhorn
Loretta A. Mcquaid
Leland O. Weigel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James E. Audia, Kenneth S. Hirsch, Charles D. Jones, David E. Lawhorn, Loretta A. Mcquaid, Leland O. Weigel filed Critical James E. Audia
Publication of BR1100393A publication Critical patent/BR1100393A/pt

Links

BR1100393-6A 1991-08-21 1997-04-30 Composto e formulação farmacêutica BR1100393A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74811691A 1991-08-21 1991-08-21

Publications (1)

Publication Number Publication Date
BR1100393A true BR1100393A (pt) 1999-08-31

Family

ID=25008093

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100393-6A BR1100393A (pt) 1991-08-21 1997-04-30 Composto e formulação farmacêutica

Country Status (2)

Country Link
BR (1) BR1100393A (pt)
ZA (1) ZA926285B (pt)

Also Published As

Publication number Publication date
ZA926285B (en) 1994-02-21

Similar Documents

Publication Publication Date Title
BR1100329A (pt) Composto e formulação farmacêutica
FI934914A (fi) Farmaceutiska formuleringar
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
BR1100824A (pt) Composto e composição farmacêutica
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
DK0515312T3 (da) Farmaceutisk præparat
FI921060A (fi) Farmaceutiska aerosolformuleringar
DE69224656T2 (de) Arzneimittel
FI923581A (fi) Farmaceutisk kombinationsformation
BR9200058A (pt) Composto e composicao farmaceutica
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
DK0511991T3 (da) Farmaceutisk formulering
BR9606066A (pt) Composto e formulação farmacêutica
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
NO178066C (no) Substituert sulfonamidderivat og farmasöytisk formulering inneholdende det samme
BR1100393A (pt) Composto e formulação farmacêutica
DK136492D0 (da) A pharmaceutical formulation
BR1100596A (pt) Composto e formulações farmacêuticas
BR1100486A (pt) Composto e composição farmacêutica
NO920564L (no) Farmasoeytiske adenosinholdige preparater
SE9101348D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
MT Patent suspended - articles 230 and 231 of law 9279/96
MT Patent suspended - articles 230 and 231 of law 9279/96
NB Patent issued - articles 230 and 231 of law 9279/96
RLL Other requests - articles 230 and 231 of law 9279/96